RecruitingGynecologic CancerImmunotherapyGut Microbiome
Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy
Eligible age
18+ yrs
Accepts
Women
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
30 participants with advanced or recurrent gynecological cancer from are enrolled for this study. Eligible participants then provide fecal specimen, blood, vaginal swab, oral mucosal swab and receive food dietary recommendation. Additional samples are collected for results analysis.
Sponsor: Viome
You may qualify if…
- ✓ Adult females \> 18 years old
- ✓ Advanced or recurrent gynecological cancer patients from AHMG Advent Health Orlando Gynecologic Oncology Group
- ✓ Patients for whom an immunotherapy regimen has been ordered
You may not qualify if…
- ✕ Patients unable to provide fecal specimens at three time points
- ✕ Patients unable to read or understand informed consent
- ✕ Taking medications that may affect gut microbiome:
- ✕ Proton pump inhibitors (PPIs)
- ✕ Metformin
- ✕ Antibiotics
- ✕ Laxatives
- ✕ Patients who are receiving investigational agent
Where it's recruiting
Florida
Orlando
Source: ClinicalTrials.gov · NCT04957511 · last updated 2025-01-29